Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/08 → 2/28/10 |
Funding
- Bavarian Nordic A/S (POX-MVA-008 // HHSN266200400072C)
- National Institute of Allergy and Infectious Diseases (POX-MVA-008 // HHSN266200400072C)
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA-BN (IMVAMUNE) Smallpox Vaccine in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
- Laumann, Anne E (PD/PI)
- West, Dennis P (Co-Investigator)
Project: Research project